NKY(300109)2023-04-26 16:00Financial Performance - The company's revenue for Q1 2023 was ¥363,003,583.47, representing a 16.77% increase compared to ¥310,869,875.29 in the same period last year[4] - Net profit attributable to shareholders reached ¥119,979,801.13, a significant increase of 267.98% from ¥32,604,859.37 year-on-year[4] - Basic earnings per share increased to ¥0.39, up 290.00% from ¥0.10 in the same quarter last year[4] - Operating profit significantly improved to ¥154,728,205.01, up from ¥44,095,556.29, marking an increase of 250.5%[27] - Net profit for the current period was ¥119,313,647.55, compared to ¥31,554,115.42 in the previous period, reflecting a growth of 278.5%[27] - The company reported a total comprehensive income of ¥119,468,991.30, compared to ¥31,741,429.97 in the previous period, an increase of 276.5%[28] Cash Flow - The net cash flow from operating activities was ¥104,812,243.03, a 159.99% improvement from a negative cash flow of ¥174,723,246.02 in the previous year[4] - Cash inflow from operating activities totaled ¥357,576,096.52, slightly down from ¥360,232,183.38 in the previous period[30] - The company reported a total cash outflow of ¥73,643,622.61 for the quarter, compared to a cash outflow of ¥363,589,918.13 in the previous year[31] - Total cash outflow from investing activities was ¥181,329,902.33, compared to ¥48,915,893.14 in the same period last year, resulting in a net cash flow from investing activities of -¥180,410,623.98[31] - Cash inflow from financing activities amounted to ¥6,500,000.00, an increase from ¥2,039,500.00 in Q1 2022, leading to a net cash flow from financing activities of ¥3,702,270.27[31] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,793,407,270.55, reflecting a 2.15% increase from ¥3,713,523,107.73 at the end of the previous year[4] - The total liabilities decreased from 596,286,950.89 yuan at the beginning of the year to 557,069,733.15 yuan[25] - The company's total equity increased from 3,117,236,156.84 yuan to 3,236,337,537.40 yuan[25] - The company held long-term equity investments valued at 114,691,584.83 yuan, up from 14,393,865.83 yuan at the beginning of the year[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 16.232 million[13] - The largest shareholder, Wang Donghu, holds 8.66% of shares, amounting to 28,063,481 shares, with 22,441,972 shares pledged[13] - Wang Jianqiang, the second-largest shareholder, owns 4.86% of shares, totaling 15,731,091 shares, with 8,274,390 shares pledged[13] - The top ten shareholders include various institutional investors, with the largest being CITIC Securities and Wuhu Great Wall Guolong Investment Management Co., holding 3.95% and 3.91% respectively[13] - The total number of restricted shares at the beginning of the period was 56,497,025, with 14,095,217 shares released during the period[17] Strategic Initiatives - The company is actively managing its shareholder structure, with a focus on maintaining control among key stakeholders[14] - The report indicates a strategic focus on retaining key executives through share lock-up agreements[17] - The company is preparing for future growth by ensuring a stable shareholder base and aligning interests with management through equity incentives[18] - The company acquired a 13% stake in Suzhou Dongsheng Xingye Scientific Instrument Co., Ltd. for 5.2 million yuan through its wholly-owned subsidiary Changsha Sanji Biotechnology Co., Ltd.[19] - The company granted 3 million restricted shares to its chief scientist Herbert Wilhelm Ulmer at a price of 1.00 yuan per share as part of its 2023 restricted stock incentive plan[19] Operational Efficiency - The company's cash flow from operating activities showed a positive trend, indicating improved operational efficiency compared to the previous year[31] - Financial expenses decreased by 77.27% to -¥1,281,367.91, attributed to a reduction in interest income[10] - Research and development expenses increased to ¥11,097,533.95 from ¥10,738,557.48, showing a rise of 3.4%[27] - Other income increased by 295.35% to ¥3,157,658.46, mainly due to an increase in government subsidies related to production operations[10] - The company experienced a foreign exchange loss of ¥1,747,511.93 during the quarter[31]